Over the years, Pharmetheus has contributed to the establishment and maintenance of a model-informed drug development (MIDD)-mindset within a wide range of pharmaceutical companies.

We have done so by enhancing collaboration across a variety of disciplines including statisticians, clinical pharmacologists, and clinicians.

These collaborations have underpinned the development of a quantitative framework where a variety of fit-for-purpose modeling approaches have been integrated to support and inform development program strategies and decisions most effectively and efficiently.

Choosing a strategy on how to leverage data from different programs to better understand a disease, a clinical endpoint, or a placebo response can be a challenge and hinder efficiencies.

Establishing collaboration between quantitative approaches and functions is important but also context-of-use dependent.

Pharmetheus houses the relevant team experience and expertise to support you at these stages, and our tailored MIDD Pharmetheus Platform solutions help organizations build greater efficiencies, awareness, and source untapped potential.

We draw from a variety of platforms’ ways of working and solutions to assist your team in planning and conducting efficient analyses of collected data. Here are the Pharmetheus Platforms that can be leveraged.

Depending on your unique circumstances, we select or combine: